Background illustration for clinical trials search

Paid Clinical Trials High Point

Discover 1,729 paid clinical trials in High Point, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

Tafasitamab and Rituximab for Front-Line Treatment of Post-Transplant Lymphoproliferative Disorder

for
Monomorphic B-Cell Post-Transplant Lymphoproliferative Disorder,
Location: Hillsborough NC, Columbus OH, New Brunswick NJ,
Sponsor: Timothy Voorhees

Sex: All

Age: 18+

Code: NCT05786040

Phase2, Recruiting
Active & Responsive

A Study of TAK-360 in Adults With Idiopathic Hypersomnia

for
Idiopathic Hypersomnia
Location: Huntersville NC, Denver NC, Columbia SC, Norfolk VA,
Sponsor: Takeda

Sex: All

Age: 18 - 70

Code: NCT06812078

Phase2, Recruiting
Active & Responsive

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

for
NASH - Nonalcoholic Steatohepatitis,
Location: Statesville NC, Chapel Hill NC, Durham NC, Charlotte NC,
Sponsor: Akero Therapeutics, Inc

Sex: All

Age: 18 - 70+

Code: NCT06528314

Phase3, Recruiting
Active & Responsive

A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis

for
NASH With Fibrosis, MASH With Fibrosis
Location: Statesville NC, Chapel Hill NC, Durham NC, Charlotte NC,
Sponsor: Akero Therapeutics, Inc

Sex: All

Age: 18 - 70+

Code: NCT06215716

Phase3, Recruiting
Active & ResponsiveNew

Daily Upgrade Trial

for
Healthy Women
Location: Chapel Hill NC
Sponsor: University of North Carolina, Chapel Hill

Sex: Female

Age: 25 - 45

Code: NCT07792603

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

for
Advanced Endometrial Carcinoma, Recurrent Endometrial Carcinoma
Location: Chapel Hill NC, Durham NC, Raleigh NC, Clinton NC,
Sponsor: National Cancer Institute (NCI)

Sex: Female

Age: 18+

Code: NCT07198074

Phase3, Recruiting
Active & Responsive

Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment

for
Metastatic Head and Neck Squamous Cell Carcinoma,
Location: Chapel Hill NC, Pinehurst NC, Hendersonville NC,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06589804

Phase3, Recruiting
Active & Responsive

A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment

for
Lung Non-Small Cell Carcinoma
Location: Chapel Hill NC, Washington PA, Greensburg PA,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT07293247

Phase2, Recruiting
Active & Responsive

A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)

for
Non-small Cell Lung Cancer
Location: Chapel Hill NC, Raleigh NC, Asheville NC,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07513376

Phase3, Recruiting
Active & Responsive

PREDICT-RD: ctDNA Surveillance in TNBC With Residual Disease

for
Breast Cancer, Residual Disease,
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT07069595

Phase2, Recruiting
Active & Responsive

Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma

for
Pleuropulmonary Blastoma
Location: Chapel Hill NC, Durham NC, Charlottesville VA,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 21

Code: NCT06647953

Phase3, Recruiting
Active & Responsive

CARED : A Novel Rapid Treatment Paradigm for Depression

for
Major Depressive Disorder
Location: Chapel Hill NC
Sponsor: University of North Carolina, Chapel Hill

Sex: All

Age: 18 - 70

Code: NCT07507370

Recruiting
Active & Responsive

Modulation of Brain Rhythms in Stroke

for
Stroke
Location: Chapel Hill NC
Sponsor: University of North Carolina, Chapel Hill

Sex: All

Age: 45 - 70+

Code: NCT07121582

Recruiting
Active & Responsive

Focusing on the Menopausal Transition to Improve Mid-Life Women's Health

for
Menopause, Menopause Hot Flashes, Menopause Related Conditions,
Location: Chapel Hill NC, Richmond VA, Aurora CO
Sponsor: University of Colorado, Denver

Sex: Female

Age: 45 - 55

Code: NCT06975111

Phase2, Phase3, Recruiting
Active & Responsive

Global Paradise System US Post Approval Study

for
Hypertension, Cardiovascular Diseases, Vascular Diseases
Location: Chapel Hill NC, Durham NC, Spartanburg SC, Columbia SC,
Sponsor: ReCor Medical, Inc.

Sex: All

Age: 18+

Code: NCT06297291

Recruiting
Active & Responsive

Treatment of Inflammatory Myelitis and Optic Neuritis With Early vs Rescue Plasma Exchange (TIMELY-PLEX)

for
Optic Neuritis, Myelitis, Myelitis, Transverse
Location: Chapel Hill NC, Durham NC, Charlottesville VA,
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT07100990

Phase3, Recruiting
Active & Responsive

Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)

for
Generalized Myasthenia Gravis
Location: Chapel Hill NC, Durham NC, Charlotte NC, Augusta GA,
Sponsor: Alexion Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT04202341

Recruiting
Active & Responsive

Belimumab With Rituximab for Primary Membranous Nephropathy

for
Membranous Nephropathy, Nephrotic Syndrome
Location: Chapel Hill NC, Bethesda MD, Baltimore MD, Columbus OH,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 18 - 70+

Code: NCT03949855

Phase2, Recruiting
Active & Responsive

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

for
Crohn's Disease
Location: Chapel Hill NC, Charlotte NC, Richmond VA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 16 - 70+

Code: NCT06430801

Phase3, Recruiting
Active & Responsive

Gastroschisis Outcomes of Delivery (GOOD) Study

for
Gastroschisis
Location: Chapel Hill NC, Charlottesville VA, Atlanta GA,
Sponsor: Medical College of Wisconsin

Sex: Female

Age: 18+

Code: NCT02774746

Recruiting